Chimeric antigen receptor (CAR) T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Hansch L, Peipp M, Mastall M, Villars D, Myburgh R, Silginer M, Weiss T, Gramatzki D, Vasella F, Manz MG, Weller M, Roth P
Neuro Oncol. 2023 Jun 19:noad108. doi: 10.1093/neuonc/noad108. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.